Top compounds associated with response to CCT3


Feature Type Standardized
Nominal ANOVA
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.18 3e-07
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.19 4e-07
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.19 5e-07
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.18 6e-07
mRNA KX2-391 CTRPv2 pan-cancer AAC 0.16 7e-07
mRNA Vorinostat GDSC1000 pan-cancer AAC 0.16 2e-06
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.18 3e-06
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 3e-06
mRNA FK866 GDSC1000 pan-cancer AAC 0.15 3e-06
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 4e-06
Download CSV